CABG was associated with a 41% lower risk of long-term mortality than PCI in a new study of more than 57,000 patients. The full analysis was published in European Heart Journal.

Christoph Wald, MD, vice chair of the ACR Board of Chancellors, explains how the new Assess-AI National Radiology Data Registry is designed to help monitor accuracy and other metrics for radiology artificial intelligence.

Michael Reardon, MD, co-principal investigator of the ACURATE IDE trial, discussed updated data on what may have impacted that study's findings.

New research out of Denmark explored how undergoing TAVR may or may not influence the final year of a patient's life.

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

The American College of Cardiology published an expert consensus on practical approaches for arrhythmia monitoring after stroke to improve post-stroke care by identifying and managing atrial fibrillation.

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

Mark Isenberg, executive vice president of Zotec Partners, discusses key developments that will reshape the specialty this year.